Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
EMBC
ENTA
Add up to 3 more stocks
EMBC
Embecta Corp.
+1.19%
$5.95+0.07Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$353.00M
52W Range
$2.77 - $14.91
ENTA
Enanta Pharmaceuticals, Inc.
-3.41%
$12.17-0.43Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$353.88M
52W Range
$10.20 - $17.15
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 4.02 | N/A |
| Forward P/E | 3.38 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 3.50 |
| P/S Ratio | 0.35 | 5.42 |
| P/FCF Ratio | 2.14 | N/A |
| EV/EBITDA | 5.38 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 59.9% | 98.2% |
| Operating Margin | 24.9% | -130.7% |
| Net Margin | 8.6% | -96.9% |
| ROE | N/A | -62.6% |
| ROA | 6.9% | -21.3% |
| ROIC | 18.0% | -24.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.68 | 3.76 |
| Quick Ratio | 1.68 | 3.76 |
| Debt/Equity | N/A | 0.55 |
| Interest Coverage | 3.07 | -11.11 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 5.4% | N/A |
| Payout Ratio | 21.6% | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.